Your browser doesn't support javascript.
loading
Using a qPCR device to screen for modulators of ABC transporter activity: A step-by-step protocol.
Möhle, Luisa; Schwarzová, Barbora; Krohn, Markus; Stefan, Sven Marcel; Pahnke, Jens.
Afiliação
  • Möhle L; Department of Neuro-/Pathology, University of Oslo & Oslo University Hospital, Oslo, Norway; Department of Bioorganic Chemistry, Leibniz-Institute of Plant Biochemistry, Halle, Germany. Electronic address: luisa.mohle@medisin.uio.no.
  • Schwarzová B; Department of Neuro-/Pathology, University of Oslo & Oslo University Hospital, Oslo, Norway.
  • Krohn M; Department of Neuro-/Pathology, University of Oslo & Oslo University Hospital, Oslo, Norway.
  • Stefan SM; Department of Neuro-/Pathology, University of Oslo & Oslo University Hospital, Oslo, Norway; Pharmaceutical and Cell Biological Chemistry, Pharmaceutical Institute, University of Bonn, Germany.
  • Pahnke J; Department of Neuro-/Pathology, University of Oslo & Oslo University Hospital, Oslo, Norway; Department of Bioorganic Chemistry, Leibniz-Institute of Plant Biochemistry, Halle, Germany; LIED, University of Lübeck, Germany; Department of Pharmacology, Medical Faculty, University of Latvia, Riga,
J Pharmacol Toxicol Methods ; 104: 106882, 2020.
Article em En | MEDLINE | ID: mdl-32474136
ABSTRACT

INTRODUCTION:

Adenosine triphosphate (ATP)-binding cassette (ABC) transporters are transmembrane proteins which actively transport a large variety of substrates across biological membranes. ABC transporter overexpression can be the underlying cause of multidrug resistance in oncology. Moreover, it has been revealed that increased ABCC1 transporter activity can ameliorate behavioural changes and Aß pathology in a rodent model of Alzheimer's disease and it is currently tested in AD patients.

METHODS:

Finding substances that modulate ABC transporter activity (inhibitors and activators) is of high relevance and thus, different methods have been developed to screen for potential modulators. For this purpose, we have developed a cell-based assay to measure the kinetics of ABCC1-mediated efflux of a fluorescent dye using a common qPCR device (Agilent AriaMx).

RESULTS:

We validated the specificity of our method with vanadate and benzbromarone controls. Furthermore, we provide a step-by-step protocol including statistical analysis of the resulting data and suggestions how to modify the protocol specifically to screen for activators of ABCC1.

DISCUSSION:

Our approach is biologically more relevant than cell-free assays. The continuous detection of kinetics allows for a more precise quantification compared with assays with single end-point measurements.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas Associadas à Resistência a Múltiplos Medicamentos / Reação em Cadeia da Polimerase em Tempo Real / Corantes Fluorescentes Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: J Pharmacol Toxicol Methods Assunto da revista: FARMACOLOGIA / TOXICOLOGIA Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas Associadas à Resistência a Múltiplos Medicamentos / Reação em Cadeia da Polimerase em Tempo Real / Corantes Fluorescentes Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: J Pharmacol Toxicol Methods Assunto da revista: FARMACOLOGIA / TOXICOLOGIA Ano de publicação: 2020 Tipo de documento: Article